Sonnet BioTherapeutics Holdings, Inc.
SONN
$3.47
$0.092.66%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.00M | 1.00M | 1.00M | 18.60K | 55.90K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.00M | 1.00M | 1.00M | 18.60K | 55.90K |
| Cost of Revenue | 1.77M | 1.07M | 1.35M | 109.30K | -5.31M |
| Gross Profit | -767.60K | -69.00K | -351.40K | -90.70K | 5.37M |
| SG&A Expenses | 7.66M | 8.08M | 7.44M | 6.13M | 5.95M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 15.06M | 14.78M | 14.42M | 11.87M | 12.33M |
| Operating Income | -14.06M | -13.78M | -13.42M | -11.85M | -12.28M |
| Income Before Tax | -13.40M | -13.13M | -9.27M | -7.44M | -7.99M |
| Income Tax Expenses | 158.40K | 158.40K | 158.40K | -- | -- |
| Earnings from Continuing Operations | -13.56 | -13.29 | -9.43 | -7.44 | -7.99 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -13.56M | -13.29M | -9.43M | -7.44M | -7.99M |
| EBIT | -14.06M | -13.78M | -13.42M | -11.85M | -12.28M |
| EBITDA | -14.05M | -13.77M | -13.41M | -11.84M | -12.26M |
| EPS Basic | -6.73 | -11.35 | -9.82 | -10.72 | -24.14 |
| Normalized Basic EPS | -4.16 | -7.04 | -6.09 | -6.70 | -15.09 |
| EPS Diluted | -6.73 | -11.35 | -9.86 | -10.76 | -24.18 |
| Normalized Diluted EPS | -4.16 | -7.04 | -6.11 | -6.72 | -15.11 |
| Average Basic Shares Outstanding | 10.85M | 7.51M | 4.17M | 2.62M | 1.90M |
| Average Diluted Shares Outstanding | 10.85M | 7.51M | 4.20M | 2.66M | 1.93M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |